The relative prognostic value of plasma HIV RNA levels and CD4 lymphocyte counts in advanced HIV infection

AIDS

Volumn 12, Issue 13, 1998, Pages 1639-1643

  Lepri, Alessandro Cozzi ^a   Katzenstein, Terese L ^b   Ullum, Henrik ^b   Phillips, Andrew N ^a   Skinhøj, Peter ^b   Gerstoft, Jan ^b   Pedersen, Bente K ^b  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b University of Copenhagen   (Denmark)

Author keywords

HIV progression; Prognostic value; Statistical interaction

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; VIRUS RNA;

ADULT; ARTICLE; COHORT ANALYSIS; DEATH; DENMARK; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; SURVIVAL TIME; T LYMPHOCYTE; VIRUS LOAD;

ADULT; AGED; BIOLOGICAL MARKERS; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HIV; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RNA, VIRAL; VIRAL LOAD;

EID: 7344250683     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199813000-00011     Document Type: Article

References (33)

1. Piatak M, Saag MS, Yang LC, et al.: High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science 1995; 259:1749-1754.
2. Ho DD, Moudgil T, Alam M: Quantitation of HIV-1 in the blood of infected persons. N Engl J Med 1989, 321:1621-1625.
3. Coombs RW, Collier AC, Allin J-P, et al.: Plasma viraemia in HIV infection. N Engl J Med 1989, 321:1626-1631.
4. Semple M, Loveday C, Weller I, et al.: Direct measurement of viraemia in patients infected with HIV-1 and its relationship to disease progression and zidovudine therapy. J Med Virol 1991, 35:38-45.
5. Loveday C. Hill A: Prediction of progression to AIDS with serum HIV-1 RNA and CD4 count. Lancet 1995, 345:790-791.
6. Henrard DR, Phillips JF, Muenz LR, et al.: Natural history of HIV-1 cell-free viraemia. JAMA 1995, 274:554-558.
7. Mellors JW, Kingsley LA, Rinaldo CR, et al.: Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion. Ann Intern Med 1995, 122:573-579.
8. Ruffault A, Michelet C, Jacquelinet C, et al.: The prognostic value of plasma viraemia in HIV-infected patients under AZT treatment: a two-year follow-up study. J Acquir Immune Defic Syndr 1995, 9:243-248.
9. Greenberg BL, Schoenbaum EE, Farzadegan H, et al.: Viral load and HIV disease progression in a cohort of former and current injecting drug users (IDUs). 4th Conference on Retroviruses and Opportunistic Infections, Washington, DC, January 1997 [abstract 474].
10. Marschner I, De Gruttola V, Saag M, for the ACTG Cross Protocol Study Group: Prognostic value of CD4 counts and plasma HIV RNA: an ACTG cross protocol analysis. 4th Conference on Retroviruses and Opportunistic Infections, Washington, DC, January 1997 [abstract 476].
11. Hubert JB, Meyer L, Dussaix E, et al.: Prognostic value of early HIV-1 RNA levels on disease progression in 363 patients with a known date of infection. 4th Conference on Retroviruses and Opportunistic Infections, Washington, DC, January 1997 [abstract 478].
12. + lymphocyte counts and the risk of progression to AIDS. N Engl J Med 1996, 334:426-431.
13. Mellors JW, Rinaldo Jr CR. Gupta P, et al.: Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 1996, 272:1167-1170.
14. Lafeuillade A, Tamalet C., Pellegrino P, et al.: Correlation between surrogate markers, viral load and disease progression in HIV-1 infection. J Acquir Immune Defic Syndr 1994, 7:1028-1033.
15. Schechter MT, Neumann PW, Weaver MS, et al.: Low HIV-1 proviral DNA burden detected by negative PCR in seropositive individuals correlates with slower disease progression. AIDS 1991, 5:373-379.
16. Venet A, Lu W. Beldjord K, et al.: Correlation between CD4 cell counts and cellular and plasma viral load in HIV-1 seropositive individuals. AIDS 1991, 5:283-288.
17. Lefrere JJ, Mariotti M, Wattel E, et al.: Towards a new predictor of AIDS progression through the quantilation of HIV-1 DNA copies by PCR in HIV-infected individuals. Br J Haematol 1992, 82:467-471.
18. Ferre F, Marchese A, Duffy PC, et al.: Quantitation of HIV viral burden by PCR in HIV seropositive Navy personnel representing Walter Reed stages 1 to 6. AIDS Res Hum Retroviruses 1992, 8:269-275.
19. Phillips AN, Eron JJ, Bartlett JA, et al.: HIV-1 RNA levels and the development of clinical disease. AIDS 1997, 10:859-865.
20. Welles SL, Jackson JB, Yen-Lieberman B, et al.: Prognostic value of plasma human immunodeficiency virus type 1 (HIV-1) RNA levels in patients with advanced HIV-1 disease and with little or no prior zidovudine therapy. J Infect Dis 1996, 174:696-703.
21. Mellors JW, Munoz A, Giorgi JV, et al.: Plasma viral load and CD4 lymphocytes as prognostic markers of HIV-1 infection. Ann Intern Med 1997, 126:946-954.
22. Galetto-Lacour A, Yerly S, Perneger TV, et al.: Prognostic value of viremia in patients with long-standing human immunodeficiency virus infection. J Infect Dis 1996, 173:1388-1393.
23. Yerly S, Perneger T, Hirschel B, et al.: HIV viraemia influences survival in HIV infected patients. XI International Conference on AIDS. Vancouver, July 1996 [abstract We.B413].
24. Spijkerman IJB, Prins M, Goudsmith J, et al.: Early and late HIV-1 RNA level and its association with other markers and disease progression in long-term AIDS-free homosexual men. AIDS 1997, 11:1383-1388.
25. + T-cell count and function: markers with reciprocal predictive value over time after seroconversion. AIDS 1997, 11:1799-1806.
26. Ullum H, Gotzsche PC, Victor J, et al.: Defective natural immunity - an early manifestation of human immunodeficiency virus infection. J Exp Med 1995, 182:789-800.
27. Dunne AL, Crowe SM: Comparison of branched DNA and reverse transcriptase polymerase chain reaction for quantifying six different HIV-1 subtypes in plasma [letter]. AIDS 1997, 11:126-127.
28. Vandamme A-M, Schmit J-C, Van Dooren S, et al.: Quantification of HIV-1 RNA in plasma: comparable results with the NASBA HIV-1 RNA QT and the AMPLICOR HIV monitor test. J Arquir Immune Defic Syndr 1996, 2:127-139.
29. Koot M, Keel JP, Vos AH, et al.: Prognostic value of HIV-1 syncytium-inducing phenotype for rate of CD4 cell depletion and progression to AIDS. Ann Intern Med 1993 118:681-688.
30. Keet IPM, Janssen M, Veuglers PJ, et al.: Longitudinal analysis of CD4 T cell counts, T cell reactivity, and human immunodeficiency virus type 1 RNA levels in persons remaining AIDS-free despite CD4 cell counts < 200 for > 5 years. J Infect Dis 1997, 176: 665-671.
31. Cameron B, Heath-Chiozzi M, Kravcik S, et al.: Prolongation of life and prevention of AIDS in advanced HIV immunodeficiency with ritonavir. 3rd Conference on Retroviruses and Opportunistic Infections. Washington, DC, January - February 1996.
32. Phillips AN, Eron I, Bartlett J, et al.: Correspondence between the effect of zidovudine plus lamivudine on plasma HIV level/CD4 lymphocyte count and the incidence of clinical disease in infected individuals. AIDS 1997, 11:169-175.
33. Egger M, Hirschel B, Francioli P, et al.: Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre study. BMJ 1997, 315:1194-1199.